Published in Science on August 30, 1974
Shoe-makers' polyneuropathy in Italy: the aetiological problem. Br J Ind Med (1976) 1.24
Toxic polyneuropathy of shoe-industry workers. A study of 122 cases. J Neurol Neurosurg Psychiatry (1976) 1.24
Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry (1975) 1.21
Relationship between clinical and electromyographic findings and exposure to solvents, in shoe and leather workers. Br J Ind Med (1978) 1.00
Health effects among refrigeration repair workers exposed to fluorocarbons. Br J Ind Med (1986) 0.98
Animal models of peripheral neuropathy due to environmental toxicants. ILAR J (2014) 0.83
Neurophysiological studies on the relation between the structural properties and neurotoxicity of aliphatic hydrocarbon compounds in rats. Br J Ind Med (1984) 0.80
Environmental effects on the central nervous system. Environ Health Perspect (1977) 0.76
Peripheral neuropathy following intentional inhalation of naphtha fumes. Can Med Assoc J (1984) 0.76
Neurotoxic properties of certain aliphatic hexacarbons. Proc R Soc Med (1977) 0.75
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00
Survey of patients' satisfaction with access to general practitioners. J R Coll Gen Pract (1988) 5.30
The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28
A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg (1978) 3.91
Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring. Nat Cell Biol (1999) 3.28
Prognostic factors in acute pancreatitis. Gut (1984) 2.94
Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem (1992) 2.90
Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect (2003) 2.77
Isolation of a mutant Arabidopsis plant that lacks N-acetyl glucosaminyl transferase I and is unable to synthesize Golgi-modified complex N-linked glycans. Plant Physiol (1993) 2.68
Inclusion body myositis and myopathies. Ann Neurol (1995) 2.68
Cellular mechanisms regulating [Ca2+]i smooth muscle. Annu Rev Physiol (1989) 2.67
Correlating phenotype and genotype in the periodic paralyses. Neurology (2004) 2.55
The genesis and collapse of third millennium north mesopotamian civilization. Science (1993) 2.33
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2003) 2.32
Characteristics of Ca2+- and Mg2+-induced tension development in chemically skinned smooth muscle fibers. J Gen Physiol (1978) 2.29
Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med (1986) 2.22
Transport into mitochondria and intramitochondrial sorting of the Fe/S protein of ubiquinol-cytochrome c reductase. Cell (1986) 2.21
A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nat Genet (1995) 2.17
Liaison psychiatry in general practice: a comparison of the liaison-attachment scheme and shifted outpatient clinic models. J R Coll Gen Pract (1989) 2.17
Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology (1991) 2.16
Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve (1981) 2.06
Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve (1983) 1.99
Abnormalities identified in the knees of asymptomatic volunteers using peripheral magnetic resonance imaging. Osteoarthritis Cartilage (2005) 1.98
Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology (1989) 1.90
Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol (1989) 1.88
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet (1992) 1.81
The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol (1991) 1.81
Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol (1999) 1.81
Hyponatremia resulting from apparently inappropriate secretion of antidiuretic hormone in patients with pulmonary tuberculosis. Am Rev Respir Dis (1965) 1.80
Chlorine dioxide metabolism in rat. J Environ Pathol Toxicol (1979) 1.79
Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol (1991) 1.78
Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months) Neurology (1993) 1.75
Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology (2001) 1.75
Social work in general practice. J R Coll Gen Pract (1978) 1.74
Importance of the pleckstrin homology domain of dynamin in clathrin-mediated endocytosis. Curr Biol (1999) 1.72
Staphylococcal and streptococcal colonization of the newborn infant: effect of antiseptic cord care. Am J Dis Child (1977) 1.70
Morphometric X-ray absorptiometry of the spine: correlation in vivo with morphometric radiography. Study of Osteoporotic Fractures Research Group. Osteoporos Int (1994) 1.70
Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation. Hum Mol Genet (1993) 1.67
Isolation and characterization of the proton-translocating NADH: ubiquinone oxidoreductase from Escherichia coli. Eur J Biochem (1995) 1.66
Patient access and appointment systems. Practitioner (1988) 1.65
Characterization of Neurospora crassa mitochondria prepared with a grind-mill. Eur J Biochem (1970) 1.64
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology (2005) 1.63
Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D. Neurology (2008) 1.63
Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology (1999) 1.62
Nosocomial transmission of group B streptococci. Pediatrics (1976) 1.62
Toxic polyneuropathy due to methyl n-butyl ketone. An industrial outbreak. Arch Neurol (1975) 1.62
Is an early ultrasound scan of value in acute pancreatitis? Br J Surg (1982) 1.61
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol (1983) 1.60
Migratory pneumonia with eosinophilia associated with sulfonamide administration. Arch Intern Med (1967) 1.57
Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet (1998) 1.56
The clinical course of serpiginous choroidopathy. Am J Ophthalmol (1979) 1.54
Sex of parent transmission effect in Tourette's syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology (1997) 1.54
A CREB-binding site as a target for decapentaplegic signalling during Drosophila endoderm induction. EMBO J (1997) 1.52
Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology (1993) 1.52
Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol (1994) 1.52
An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. Hum Mol Genet (1996) 1.52
Cystic kidneys. Genetics, pathologic anatomy, clinical picture, and prenatal diagnosis. Hum Genet (1984) 1.51
Predictors of sun exposure in adolescents in a southeastern U.S. population. J Adolesc Health (1996) 1.50
Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer (1997) 1.50
Quality improvement in neurology residency programs. Report of the Quality Improvement Committee of the Association of University Professors of Neurology. Neurology (1997) 1.49
The primary structure of the iron-sulfur subunit of ubiquinol-cytochrome c reductase from Neurospora, determined by cDNA and gene sequencing. Eur J Biochem (1985) 1.46
Peripheral nerve vasculitis: immune characterization of the vascular lesions. Ann Neurol (1989) 1.46
The proton-pumping respiratory complex I of bacteria and mitochondria and its homologue in chloroplasts. FEBS Lett (1995) 1.46
Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer. Gynecol Oncol (2003) 1.45
Congenital myopathy with type II muscle fiber hypoplasia. Neurology (1987) 1.43
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from urine and determination of the excretion rate for exogenous and endogenous oxytocin in human urine. J Endocrinol (1972) 1.43
The importance of local synthesis of estrogen within the breast. Steroids (1989) 1.42
Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol (1993) 1.41
Epidemic Legionnaires' disease. Airborne transmission down a chimney. JAMA (1981) 1.40
Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology (1991) 1.40
Consistent structure between bacterial and mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Mol Biol (1998) 1.38
Development of resistance to cephalosporins in clinical strains of Citrobacter spp. Antimicrob Agents Chemother (1984) 1.38
Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain (1993) 1.38
Colonoscopically placed hemoclips as treatment for massive appendiceal stump bleeding. Surg Endosc (2003) 1.37
Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (1987) 1.36
Hyperlipidaemia, alcohol abuse and acute pancreatitis. Br J Surg (1984) 1.35
Modular evolution of the respiratory NADH:ubiquinone oxidoreductase and the origin of its modules. J Theor Biol (1997) 1.35
Regulation of negative affect during mother-child problem-solving interactions: adolescent depressive status and family processes. J Abnorm Child Psychol (2000) 1.33
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology (1994) 1.33
Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology (2000) 1.31
Defective dorsal closure and loss of epidermal decapentaplegic expression in Drosophila fos mutants. EMBO J (1997) 1.31
Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg (2001) 1.30
Peripheral nerve changes induced by methyl n-butyl ketone and potentiation by methyl ethyl ketone. J Neuropathol Exp Neurol (1976) 1.30
Biogenesis of mitochondrial ubiquinol:cytochrome c reductase (cytochrome bc1 complex). Precursor proteins and their transfer into mitochondria. J Biol Chem (1982) 1.30
Acute inflammatory polyradiculoneuropathy following Hymenoptera stings. JAMA (1982) 1.29
Normal T cell development is possible without 'functional' gamma chain genes. EMBO J (1986) 1.29
Isolation of mitochondrial succinate: ubiquinone reductase, cytochrome c reductase and cytochrome c oxidase from Neurospora crassa using nonionic detergent. Eur J Biochem (1979) 1.28
Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol (1989) 1.28
Proton MRS in twin pairs discordant for schizophrenia. Mol Psychiatry (2008) 1.27
Experimental allergic neuritis induced by sensitization with galactocerebroside. Science (1979) 1.26
Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr (2002) 1.26
The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol (2000) 1.26
Electron microscopic analysis of the peripheral and membrane parts of mitochondrial NADH dehydrogenase (complex I). J Mol Biol (1991) 1.26
Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke (2003) 1.26